Nottingham Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Nottingham Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,437	Closed	-$221K	–	110
2019 Q4	$221K	Buy	+3,437	New	+$197K	0.03%	104
2018 Q3	–	Sell	-3,175	Closed	-$201K	–	102
2018 Q2	$201K	Hold	3,175	–	–	0.03%	90
2018 Q1	$201K	Sell	3,175 -455	-13%	-$29.3K	0.03%	82
2017 Q4	$222K	Buy	3,630 +55	+2%	+$3.44K	0.03%	103
2017 Q3	$228K	Sell	3,575 -925	-21%	-$54K	0.03%	101
2017 Q2	$251K	Hold	4,500	–	–	0.04%	99
2017 Q1	$245K	Sell	4,500 -183	-4%	-$10K	0.04%	99
2016 Q4	$274K	Hold	4,683	–	–	0.05%	94
2016 Q3	$253K	Hold	4,683	–	–	0.04%	94
2016 Q2	$344K	Sell	4,683 -200	-4%	-$14.1K	0.06%	66
2016 Q1	$336K	Hold	4,883	–	–	0.06%	73
2015 Q4	$336K	Buy	4,883 +512	+12%	+$33.8K	0.06%	73
2015 Q3	$259K	Sell	4,371 -543	-11%	-$34.4K	0.05%	77
2015 Q2	$327K	Buy	4,914 +43	+0.9%	+$2.83K	0.05%	77
2015 Q1	$314K	Sell	4,871 -300	-6%	-$18.8K	0.05%	78
2014 Q4	$305K	Buy	5,171 +771	+18%	+$43.5K	0.08%	70
2014 Q3	$227K	Hold	4,400	–	–	0.08%	50
2014 Q2	$213K	Hold	4,400	–	–	0.08%	49
2014 Q1	$228K	Hold	4,400	–	–	0.09%	45
2013 Q4	$233K	Hold	4,400	–	–	0.08%	47
2013 Q3	$203K	Buy	+4,400	New	+$193K	0.07%	52

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nottingham Advisors's BMY Position: Q1 2020 in Review

Nottingham Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2020, closing a stake of 3,437 shares — an estimated $221K sold.

Nottingham Advisors first reported a position in BMY in Q3 2013 and held it in 21 quarters. The position peaked at $344K in Q2 2016. 2,148 funds tracked by Wall St. Rank hold BMY as of Q1 2020.

Nottingham Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2020 after selling out during the quarter.
Nottingham Advisors sold 3,437 Bristol-Myers Squibb shares in Q1 2020, an estimated $221K.
Nottingham Advisors first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 21 quarters.
Nottingham Advisors's Bristol-Myers Squibb position peaked at $344K in Q2 2016.
2,148 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2020.

Based on Nottingham Advisors's 13F filing for Q1 2020, filed 20 Apr 2020.